Patents by Inventor Rachel Elizabeth Ropp

Rachel Elizabeth Ropp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11484492
    Abstract: Topical medicaments for the treatment of mammalian skin are provided, which include an actives fraction and a carrier fraction; the actives fraction comprises individual amounts of turmeric, Peganum harmala, and Arum palaestinum. In other embodiments, the actives fraction includes additional ingredients, including Vitamin C, ?-sitosterol, and vanillin compound(s). The medicaments are useful in the treatment of a wide variety of conditions.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: November 1, 2022
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Robert Preston Moore, Rachel Elizabeth Ropp
  • Patent number: 11358963
    Abstract: Low-temperature syntheses of thymoquinone/harmaline compounds are provided which give increased yields of desirable products having molecular weights of from about 360-380. The syntheses involve carrying out reactions between thymoquinone and harmaline and a non-interfering solvent at a temperature of less than about 10° C.
    Type: Grant
    Filed: March 5, 2020
    Date of Patent: June 14, 2022
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Rachel Elizabeth Ropp
  • Publication number: 20220160685
    Abstract: Low-temperature syntheses of thymoquinone/harmaline compounds which are useful for the treatment of human diabetes and cancers, and the derivatives, solvates, prodrugs, isomers, and tautomers of such compounds.
    Type: Application
    Filed: February 11, 2022
    Publication date: May 26, 2022
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Rachel Elizabeth Ropp, Krishna Mohan Donavalli, Rajni Verma
  • Patent number: 11246902
    Abstract: Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: February 15, 2022
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow, Robert Preston Moore, Rachel Elizabeth Ropp
  • Publication number: 20210276998
    Abstract: Low-temperature syntheses of thymoquinone/harmaline compounds are provided which give increased yields of desirable products having molecular weights of from about 360-380. The syntheses involve carrying out reactions between thymoquinone and harmaline and a non-interfering solvent at a temperature of less than about 10° C.
    Type: Application
    Filed: March 5, 2020
    Publication date: September 9, 2021
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Rachel Elizabeth Ropp
  • Publication number: 20200330372
    Abstract: Topical medicaments for the treatment of mammalian skin are provided, which include an actives fraction and a carrier fraction; the actives fraction comprises individual amounts of turmeric, Peganum harmala, and Arum palaestinum. In other embodiments, the actives fraction includes additional ingredients, including Vitamin C, ?-sitosterol, and vanillin compound(s). The medicaments are useful in the treatment of a wide variety of conditions.
    Type: Application
    Filed: April 20, 2020
    Publication date: October 22, 2020
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Robert Preston Moore, Rachel Elizabeth Ropp
  • Publication number: 20190262416
    Abstract: Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Application
    Filed: February 20, 2019
    Publication date: August 29, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow, Robert Preston Moore, Rachel Elizabeth Ropp